|
C5ORF13 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
7.1772000009851E-08 |
| Normal-vs-Stage3 |
5.55111512312578E-16 |
| Normal-vs-Stage4 |
8.29049995321185E-09 |
| Stage1-vs-Stage2 |
5.738600E-01 |
| Stage1-vs-Stage3 |
9.314400E-01 |
| Stage1-vs-Stage4 |
2.683800E-01 |
| Stage2-vs-Stage3 |
6.088000E-01 |
| Stage2-vs-Stage4 |
7.060000E-01 |
| Stage3-vs-Stage4 |
3.038800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.36759999997049E-07 |
| Normal-vs-Asian |
3.259700E-03 |
| Caucasian-vs-AfricanAmerican |
5.276000E-02 |
| Caucasian-vs-Asian |
4.057400E-01 |
| AfricanAmerican-vs-Asian |
7.166200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
6.663200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.89839999999286E-05 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
4.585100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.204200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.353000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.135200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.264200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.361800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.293000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.63300000000288E-05 |
| Normal-vs-Grade 2 |
1.62436730732907E-12 |
| Normal-vs-Grade 3 |
<1E-12 |
| Normal-vs-Grade 4 |
3.8394000001496E-07 |
| Grade 1-vs-Grade 2 |
9.337200E-01 |
| Grade 1-vs-Grade 3 |
4.120600E-01 |
| Grade 1-vs-Grade 4 |
6.164500E-02 |
| Grade 2-vs-Grade 3 |
4.196300E-02 |
| Grade 2-vs-Grade 4 |
5.015200E-04 |
| Grade 3-vs-Grade 4 |
4.000000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
1.23234755733392E-13 |
| ccA subtype-vs-ccB subtype |
1.778830E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62436730732907E-12 |
| Normal-vs-N1 |
5.384400E-01 |
| N0-vs-N1 |
2.857100E-03 |
|
|
